{"pmcid": 3936115, "prompt_strategy": "zeroshot", "model": "gpt-5.1", "extractions": [{"outcome": "The number of diverticulitis clinical symptom occurrences during 12months", "intervention": "Microencapsulated sodium butyrate (MSB) 300 mg daily", "comparator": "control group was administered placebo", "intervention_group_size": 30, "comparator_group_size": 22, "intervention_events": 2, "comparator_events": 7, "pmcid": "PMC3920747", "outcome_type": "binary"}, {"outcome": "the number of abdominal ultrasound examinations performed for suspected diverticulitis and subsequent number of diverticulitis diagnosed based on abdominal US", "intervention": "Microencapsulated sodium butyrate (MSB) 300 mg daily", "comparator": "control group was administered placebo", "intervention_group_size": 30, "comparator_group_size": 22, "intervention_events": 1, "comparator_events": 5, "pmcid": "PMC3920747", "outcome_type": "binary"}, {"outcome": "Subjective improvement in observed symptoms based on a single closed-end question (yes or no answer): \"Did you observe adequate relief of diverticulosis related to abdominal pain or discomfort within the past 12 months?\"", "intervention": "Microencapsulated sodium butyrate (MSB) 300 mg daily", "comparator": "control group was administered placebo", "intervention_group_size": 30, "comparator_group_size": 22, "intervention_events": 17, "comparator_events": 5, "pmcid": "PMC3920747", "outcome_type": "binary"}], "errors": []}
